Skip to content

Ophthalmic World Leaders

Mission

OWL works across Eyecare. Our mission is to provide professional and personal development and create opportunities for collaboration.

Vision

OWL’s vision is to promote and develop diverse leadership to advance ophthalmic innovation and patient care.

Membership Value Proposition

OWL helps eyecare industry and eyecare professionals with leadership development, education and purposeful networking throughout your career.

Mark Your Calendar

OWL Signature Event at SECO

Friday, February 27, 2026

5:00 PM - 6:30 PM

Join us at SECO to enjoy a timely and informative program, along with networking - secure your spot today!

Learn More

"Night OWL" Event at ASCRS

Thursday, April 9, 2026

8:00 PM - 9:30 PM

Join us for our new event! Enjoy an opportunity to network and meet new colleagues. Details coming soon!

Learn More

Upcoming Events

Leadership Summit

July 30-31, 2026

OLS 2026

OLS 2026

SAVE THE DATE!

OWL's annual Leadership Summit is a staple in the event calendar. Our 5th Leadership Summit will be held July 30-31.

We're working to make next year's Summit our most impactful yet! Save the date to join us in Nashville at the Gaylord Opryland Resort.

Our 2026 program details coming soon!

 

Check out highlights from OLS 2025. →

Featured Champions

Sara McLenighan

Sara McLenighan

Vice President of Sales
Iantrek

Sara McLenighan is an accomplished, award-winning sales executive known for leading high-performing teams and driving commercial excellence across the medical device, biotech, and pharmaceutical industries in the U.S. and Canada. Over the course of three decades, Sara has distinguished herself as both a builder of scalable businesses and an accelerator of market expansion—thriving in strategic leadership roles at global companies like Roche and Medtronic, as well as pioneering start-up ventures such as Nalu Medical and Axonics (now part of Boston Scientific). A results-driven Vice President of Sales, Sara’s record of achievement includes a Transformational Leadership Award, ten President’s Club honors, alongside two Rookie of the Year awards and multiple Leader of the Year distinctions at VP, Area Director, Region, and District Manager levels. She has delivered over-plan sales performance for more than five consecutive years as a Vice President and is heralded for launching first-in-class products, revitalizing portfolios, and taking new businesses from zero revenue to double-digit growth.

Sara is recognized for her ability to seamlessly integrate cross-functional leadership, data-driven strategy, and high-impact commercial execution. Her expertise spans scaling national sales organizations, optimizing territory and market development, and introducing disruptive technologies in complex, healthcare markets. Widely respected for her ability to cultivate top-tier talent, she creates cultures where excellence, innovation, and collaboration consistently produce superior results.

Deeply committed to mentorship, she plays an active role in programs that nurture young professionals and rising leaders—both within her organizations and the broader med-tech community. Sara is also engaged in broader philanthropic initiatives and professional resource groups, earning recognition for empowering others, driving purposeful change, and elevating those around her.

Rajan Shukla

Rajan Shukla

CEO
Brightstar Therapeutics

Rajan Shukla is a biotech entrepreneur, CEO and founder of Brightstar Therapeutics, and President of Vital Tears. He leads two high growth ophthalmic companies, one redefining national access to autologous serum tears, the other bringing developing advanced corneal allografts and regenerative-medicine therapeutics.

Rajan's work centers on designing modern, scalable organizations that pair scientific rigor with exceptional patient experience. At Vital Tears, he has grown the company into a nationwide network serving thousands of clinics with centralized processing, mobile phlebotomy coverage in every U.S. ZIP code, and industry-leading quality systems. At Brightstar Therapeutics, he is advancing innovative products including the BrightMEM™ decellularized corneal allograft and an emerging limbal stem-cell therapy program.

He collaborates widely across surgeons, scientists, and investors, focused on expanding the frontier of corneal care and building the next generation of ophthalmic technologies.

Scroll To Top